ERBB3 and neoplasm: HerOND used as a drug-free NBP showed no notable cytotoxicity on tumour and non-tumour cells, whereas HerDox and HerGa showed preferential cytotoxicity on the HER3+ tumour cells in contrast to the HER3− fibroblasts (Fig. 1k and Extended Data Table 1).